[ExI] Early Data Indicates an A.I.-Generated Drug Could Slow Aging

[Stuart LaForge]

I am not against using AI to invent and generate intellectual property, 
but I wonder how the laws against it will affect things like drug 
development. I mean big pharma typically won't make a drug to combat a 
disease unless they can patent it. Are they going to make an exception 
in the new AI laws for large corporations?

Stuart LaForge


On 2026-09-07 12:25, John Clark via extropy-chat wrote:
> Explore this gift article from The New York Times. You can read it for
> free without a subscription.
> 
> Early Data Indicates an A.I.-Generated Drug Could Slow Aging
> 
> Artificial intelligence was used to help develop a drug candidate,
> rentosertib, for a rare lung condition. Its maker says the drug also
> seems to reduce the biological hallmarks of age.
> 
> https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share
> [1]
> 
> Links:
> ------
> [1] 
> https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share
> _______________________________________________
> extropy-chat mailing list
> extropy-chat at lists.extropy.org
> http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat